MySheen

What are the available pneumonia vaccines?

Published: 2024-11-05 Author: mysheen
Last Updated: 2024/11/05, Children such as infants and young children are easy to get pneumonia, so there are vaccination methods for prevention and treatment. For example, 7-valent pneumonia vaccine, 13-valent pneumonia vaccine and 23-valent pneumonia vaccine are all suitable for children and adults. Here.

Children such as infants and young children are easy to get pneumonia, so there are vaccination methods for prevention and treatment. For example, 7-valent pneumonia vaccine, 13-valent pneumonia vaccine and 23-valent pneumonia vaccine are all suitable for children and adults. The price here means that it can prevent and cure several types of pneumonia, such as 23, which can prevent and cure pneumonia caused by 23 serotypes of pneumococci.

Each kind of pneumonia vaccine forms unique advantages from various aspects such as suitable population. For example, the 7-valent vaccine is the most suitable to be vaccinated at the age of 5 years, and it is one of the pediatric pneumonia vaccines. The vaccine uses protein binding technology, in which the protein acts as an immune carrier, which combines the characteristics of effective immune response to T cell dependent antigen and immune memory induced by T cell dependent antigen shortly after birth. When stimulated by the same pneumococci again, it can produce an enhanced immune response.

Seven serotypes of pneumococci with 7-valent pneumonia vaccine were 4,6B, 9V, 14,18C, 19F and 23F, respectively. Pneumococci is the main pathogen of bacterial pneumonia, which can cause pneumonia, upper respiratory tract inflammation, septicemia, meningitis, bacteremic pneumonia and bacteremia. However, when the waiter has a fever, the child should not be vaccinated until the fever has completely gone down.

23-valent pneumonia vaccine is a pneumonia vaccine suitable for healthy adults. It can prevent and cure 23 kinds of pneumococci, covering about 90% of the pneumococci most likely to cause pneumonia. Generally, protective antibodies can be produced after 2 or 3 weeks of vaccination, and the effective rate can reach more than 92% after nearly 20 years of use abroad. And it has good security, and the period of protection can reach about 5 years. Of course, after vaccination, we also need to do other aspects of prevention and protection in order to achieve the best results.

 
0